Key result
Peritoneal dialysis may provide effective ultrafiltration for selected patients with diuretic-resistant heart failure and renal impairment, requiring further study of medicoeconomic benefits.
Why the study?
Does peritoneal dialysis provide effective ultrafiltration therapy in patients with diuretic-resistant heart failure and renal impairment?
Does peritoneal dialysis provide effective ultrafiltration therapy in patients with diuretic-resistant heart failure and renal impairment?
Peritoneal dialysis is highlighted as a potentially cost-effective and efficacious ultrafiltration strategy for diuretic-resistant heart failure, though broader acceptance requires further evidence.
Hypothesis-generating for peritoneal dialysis in selected diuretic-resistant HF; prospective trials needed to confirm medicoeconomic benefits.
Heart failure (HF) is a common and important cause of morbidity and mortality in the elderly, imposing a significant burden on healthcare systems. Better management of ischemic heart disease has resulted in increased survival and growth in the number of prevalent heart failure patients, but co-existing renal impairment complicates management and limits traditional therapeutic options. Ultrafiltration (UF) techniques have shown promise in the treatment of diuretic-resistant HF, but the early successes of extracorporeal treatments has not been confirmed by randomized trials. Peritoneal dialysis (PD) may be cheaper and provide more effective UF therapy in selected patients and this review examines the issues surrounding the use of PD for such patients. Whist many nephrologists are enthusiastic about the use of this technique, making a more cogent case for PD in this setting for cardiologists is likely to need a combined strategy of demonstrating improvement in individual cases and further study of potential medicoeconomic benefits.
No takes yet. Share an insight, caveat, or question.
Puttagunta et al. (2015) conducted a review in Heart failure. Peritoneal dialysis was evaluated. Peritoneal dialysis may provide effective ultrafiltration for selected patients with diuretic-resistant heart failure and renal impairment, requiring further study of medicoeconomic benefits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: